Neo Ivy Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
121,284
+43,542
| +56% | +$1.06M | 0.94% | 14 |
|
|
2025
Q1 | $1.97M | Sell |
77,742
-62,715
| -45% | -$1.59M | 0.63% | 69 |
|
|
2024
Q4 | $3.73M | Buy |
140,457
+63,289
| +82% | +$1.68M | 0.75% | 31 |
|
|
2024
Q3 | $2.23M | Buy |
77,168
+71,500
| +1,261% | +$2.07M | 0.72% | 49 |
|
|
2024
Q2 | $159K | Buy |
+5,668
| New | +$159K | 0.03% | 197 |
|
|
2023
Q4 | – | Sell |
-19,328
| Closed | -$641K | – | 419 |
|
|
2023
Q3 | $641K | Buy |
+19,328
| New | +$641K | 0.28% | 115 |
|
|
2022
Q3 | – | Sell |
-1,554
| Closed | -$81K | – | 505 |
|
|
2022
Q2 | $81K | Sell |
1,554
-6,126
| -80% | -$319K | 0.22% | 172 |
|
|
2022
Q1 | $398K | Buy |
+7,680
| New | +$398K | 0.36% | 97 |
|
|
2021
Q4 | – | Sell |
-24,668
| Closed | -$807K | – | 584 |
|
|
2021
Q3 | $807K | Buy |
24,668
+5,893
| +31% | +$193K | 0.93% | 3 |
|
|
2021
Q2 | $735K | Buy |
18,775
+14,045
| +297% | +$550K | 0.74% | 31 |
|
|
2021
Q1 | $171K | Buy |
+4,730
| New | +$171K | 0.19% | 177 |
|
|
2020
Q4 | – | Sell |
-19,156
| Closed | -$667K | – | 539 |
|
|
2020
Q3 | $667K | Sell |
19,156
-6,844
| -26% | -$238K | 0.67% | 21 |
|
|
2020
Q2 | $807K | Buy |
+26,000
| New | +$807K | 0.93% | 3 |
|
|
2019
Q2 | – | Sell |
-5,050
| Closed | -$203K | – | 377 |
|
|
2019
Q1 | $203K | Buy |
+5,050
| New | +$203K | 0.12% | 199 |
|